{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:14:16Z","timestamp":1777900456817,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.gore.2025.101983","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:28:21Z","timestamp":1762313301000},"page":"101983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HIPEC with cisplatin desensitization at the time of secondary debulking in a patient with a prior carboplatin hypersensitivity reaction"],"prefix":"10.1016","volume":"62","author":[{"given":"Michelle","family":"Greenman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Abozenah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifang Eva","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena S.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Altwerger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2025.101983_b0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-018-2753-y","article-title":"Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer","volume":"144","author":"Altwerger","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2016.09.027","article-title":"Platinum desensitization in patients with carboplatin hypersensitivity: a single-institution retrospective study","volume":"144","author":"Altwerger","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2016.10.023","article-title":"Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin","volume":"144","author":"Bergamini","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.04.044","article-title":"Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer","volume":"197","author":"Callahan","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gore.2025.101983_b0025","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S1470-2045(24)00531-X","article-title":"Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial","volume":"25","author":"Classe","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100098","article-title":"Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgery","volume":"6","author":"El Hajj","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.gore.2025.101983_b0035","article-title":"Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions. Journal of Allergy and Clinical Immunology","volume":"3","author":"Lax","year":"2015","journal-title":"In Pract."},{"key":"10.1016\/j.gore.2025.101983_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2004.08.002","article-title":"Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions","volume":"95","author":"Lee","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.3944","article-title":"Hyperthermic Intraperitoneal Chemotherapy after Interval Cytoreductive Surgery for patients with Advanced-Stage Ovarian Cancer who had Received Neoadjuvant Chemotherapy","volume":"158","author":"Lee","year":"2023","journal-title":"JAMA Surg."},{"key":"10.1016\/j.gore.2025.101983_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2014.07.104","article-title":"Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin\/cisplatin","volume":"135","author":"Li","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0055","doi-asserted-by":"crossref","unstructured":"Markman MD, M., Kennedy, A., Webster, K., Elson, P., Peterson, G., Kulp, B., Belinson, J., 1999. Clinical features of hypersensitivity reactions to carboplatin. Journal of Clinical Oncology 17. https:\/\/doi.org\/10.1200\/jco.1999.17.4.1141.","DOI":"10.1200\/JCO.1999.17.4.1141"},{"key":"10.1016\/j.gore.2025.101983_b0060","article-title":"HIPEC with cisplatin in a patient with a prior hypersensitivity reaction to systemic oxaliplatin","volume":"127","author":"Morgan","year":"2020","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"key":"10.1016\/j.gore.2025.101983_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0070","article-title":"Outpatient desensitization in selected patients with platinum hypersensitivity reactions","volume":"145","author":"O\u2019Malley","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2025.101983_b0075","doi-asserted-by":"crossref","DOI":"10.1097\/00000421-199904000-00013","article-title":"Anaphylaxis from intraperitoneal infusion of cisplatin: a case report","volume":"22","author":"\u00d6zg\u00fcroglu","year":"1999","journal-title":"American Journal of Clinical Oncology: Cancer Clinical Trials"},{"key":"10.1016\/j.gore.2025.101983_b0080","article-title":"Low Cross-Reactivity between Cisplatin and other platinum Salts. Journal of Allergy and Clinical Immunology","volume":"7","author":"Pasteur","year":"2019","journal-title":"In Pract."},{"key":"10.1016\/j.gore.2025.101983_b0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08877-y","article-title":"Hypersensitivity Reactions to platinum Agents and Taxanes","volume":"62","author":"Tsao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.gore.2025.101983_bib91","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.gore.2025.101983_b0090","doi-asserted-by":"crossref","DOI":"10.1177\/10781552251358461","article-title":"Innovative strategies for cisplatin desensitization in hyperthermic intraperitoneal chemotherapy of ovarian cancer","author":"Villarreal-Gonz\u00e1lez","year":"2025","journal-title":"J. Oncol. Pharm. Pract."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892500308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235257892500308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:31:20Z","timestamp":1777631480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235257892500308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"alternative-id":["S235257892500308X"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2025.101983","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIPEC with cisplatin desensitization at the time of secondary debulking in a patient with a prior carboplatin hypersensitivity reaction","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2025.101983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101983"}}